Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation

Hepatology

Volumn 26, Issue 4, 1997, Pages 877-883

  Pinna, Antonio D ^a   Iwatsuki, Shunzaburo ^a,b   Lee, Randall G ^a   Todo, Satoru ^a   Madariaga, Juan R ^a   Marsh, J Wallis ^a   Casavilla, Adrian ^a   Dvorchik, Igor ^a   Fung, John J ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AZATHIOPRINE; CISPLATIN; CYCLOSPORIN; DECARBOXYPROTHROMBIN; DOXORUBICIN; PREDNISONE; TACROLIMUS; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPH NODE; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 12644252915     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260412     Document Type: Article

References (38)

1. Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of the liver in infancy and childhood. Am J Dis Child 1956;91:168-186.
2. Nagorney DM, Adson MA, Weiland LH, Knight CD, Smalley SR, Zinsmeister AR. Fibrolamellar hepatoma. Am J Surg 1985;149:113-119.
3. Ringe B, Wittekind C, Weimann A, Tusch G, Pichlmayr R. Results of hepatic resection and transplantation for fibrolamellar hepatoma. Surg Gynecol Obstet 1992;175:299-305.
4. Starzl TE, Iwatsuki S, Shaw BW, Nalesnik MA, Farhi DC, Van Thiel DH. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 1986;162: 145-148.
5. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988;19:784-794.
6. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-229.
7. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980;46:372-379.
8. Berman MM, Libbey NB, Foster JH. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma - an atypical variant with a favorable prognosis. Cancer 1980;46:1448-1455.
9. Lack EE, Neave C, Vawter GF. Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 1983;52:1510-1515.
10. Farhi DC, Shikes RH, Murari PJ, Silverberg SG. Hepatocellular carcinoma in young people. Cancer 1983;52:1516-1525.
11. Soreide O, Czerniak A, Bradpiece H, Bloom S, Blumgart L. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and review of the literature. Am J Surg 1986;151:518-523.
12. Wood WJ, Rawlings M, Evans H, Lim CNH. Hepatocellular carcinoma: importance of histologic classification as a prognostic factor. Am J Surg 1988;155:663-666.
13. Paradinas FJ, Melia WM, Wilkinson ML, Portmann B, Johnson PJ, Murray-Lyon IM, Williams R. High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J 1982;285:840-842.
14. Ruffin MT. Fibrolamellar hepatoma. Am J Gastroenterol 1990;85:577-581.
15. Saxena R, Humphreys S, Williams R, Portmann B. Nodular hyperplasia surrounding fibrolamellar carcinoma: a zone of arterialized liver parenchyma. Histopathology 1994;25:275-278.
16. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995;19:35-41.
17. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28-35.
18. Hermanek P, Sobin LH, eds. TNM Classification of Malignant Tumours, 4th edition, revised. Berlin: Springer-Verlag, 1987:53-55.
19. American Joint Committee on Cancer: Manual for Staging of Cancer. 3rd edition. Philadelphia: Lippincott, 1987:87-92.
20. Starzl TE, Bell RH, Beart RW, Putnam CW. Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet 1975;141: 429-437.
21. Starzl TE, Iwatsuki S, Shaw BW, Waterman PH, Van Thiel D, Diliz HS, Dekker A, et al. Left hepatic trisegmentectomy. Surg Gynecol Obstet 1982;155:21-27.
22. Starzl TE, Todo S, Tzakis A, Podesta L, Mieles L, Demetris A, Teperman L, et al. Abdominal organs cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989;210:374-385.
23. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of 5-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995;180:1-9.
24. Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli BJ, Malatack JJ, Schade RR, et al. Evolution of liver transplantation. HEPATOLOGY 1982;2:614-636.
25. Iwatsuki S, Starzl TE, Todo S, Gordon RD, Esquivel CO, Tzakis AG, Makowka L, et al. Experience in 1,000 liver transplants under cyclosporin-steroid therapy: a survival report. Transplant Proc 1988; 20(Suppl 1):498-504.
26. Fung JJ, Eliasziw M, Todo S, Jain A, Demetris AJ, McMichael JP, Starzl TE, et al. The Pittsburgh randomized trial of tacrolimus compared to cyclosporin for hepatic transplantation. J Am Coll Surg 1996;183:117-125.
27. Fisher LD, Van Belle G: A methodology for the health sciences. In: Biostatistics. New York: Wiley, 1993:807-808.
28. Liebman HA, Furie BC, Tong MG, Blanchard RA, Lo KJ, Lee SD, Coleman MS, et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310: 1427-1431.
29. Smalley SR, Moertel CG, Hilton JF, Weiland LH, Weiand HS, Adson MA, Melton LJ, et al. Hepatoma in noncirrhotic liver. Cancer 1988;62: 1414-1424.
30. Namieno T, Kawata A, Sato N, Kondo Y, Uchino J. Age-related, different clinico-pathologic features of hepatocellular carcinoma patients. Ann Surg 1995;221:308-314.
31. Collier NA, Wienbren K, Bloom SR, Lee YC, Hodgson HJ, Blumgart LH. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1984;1:538-540.
32. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285.
33. Haug CE, Jenkins RL, Rohrer RJ, Auchincloss H, Delmonico FL, Freeman RB, Lewis WD, et al. Liver transplantation for primary hepatic cancer. Transplantation 1992;53:376-382.
34. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-727.
35. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772-2780.
36. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219:236-247.
37. Wu CC, Ho WL, Yeh DC, Huang CR, Liu TJ, P'eng FK. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery 1996;120:34-39.
38. Fuster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taura P, et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996;223:297-302.